Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Transcriptomic profiles of tissues from rats treated with drug combinations

ABSTRACT: This SuperSeries is composed of the SubSeries listed below.

ORGANISM(S): Rattus norvegicus

PROVIDER: GSE119135 | GEO | 2018/09/11

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Transcriptomic profiles of tissues from rats treated with anticancer drug combinations.

Project description:To achieve therapeutic goals, many cancer chemotherapeutics are used at doses close to their maximally tolerated doses. Thus, it may be expected that when therapies are combined at therapeutic doses, toxicity profiles may change. In many ways, prediction of synergistic toxicities for drug combinations is similar to predicting synergistic efficacy, and is dependent upon building hypotheses from molecular mechanisms of drug toxicity. The key objective of this initiative was to generate and make publicly available key high-content data sets for mechanistic hypothesis generation as it pertains to a unique toxicity profile of a drug pair for several anticancer drug combinations. The expectation is that tissue-based genomic information that are derived from target tissues will also facilitate the generation and testing of mechanistic hypotheses. The view is that availability of these data sets for bioinformaticians and other scientists will contribute to analysis of these data and evaluation of the approach.

| S-EPMC6326153 | biostudies-literature

Transcriptomic profiles of tissues from rats treated with drug combinations [Study 2]

Project description:Combinations of anticancer agents may have synergistic anti-tumor effects, but enhanced toxicity often limit their clinical use. The risk that combinations of two or more drugs will cause adverse effects that are more severe than drugs used as monotherpies can be hypothesized from comprehensive analysis of each compound’s activity. We generated microarray gene expression data following a single dose of agents administered individually with that of the agents administered in a combination. The key objective of this initiative is to generate and make publicly available key high-content gene expression data sets for mechanistic hypothesis generation for several anticancer drug combinations. The expectation is that availability of tissue-based genomic information that are derived from target tissues will facilitate the generation and testing of mechanistic hypotheses. The view is that availability of these data sets for bioinformaticians and other scientists will contribute to analysis of these data and evaluation of the approach.

2018-09-11 | GSE119129 | GEO

Transcriptomic profiles of tissues from rats treated with drug combinations [Study 1]

2018-09-11 | GSE119122 | GEO

Transcriptomic profiles of tissues from rats treated with drug combinations [Study 3]

2018-09-11 | GSE119133 | GEO

Transcriptomic profiles of tissues from rats treated with drug combinations

Project description:Transcriptomic profiles of tissues from rats treated with drug combinations

| PRJNA488241 | ENA

Transcriptomic profiles of tissues from rats treated with drug combinations [Study 3]

Project description:Transcriptomic profiles of tissues from rats treated with drug combinations [Study 3]

| PRJNA488244 | ENA

Transcriptomic profiles of tissues from rats treated with drug combinations [Study 2]

Project description:Transcriptomic profiles of tissues from rats treated with drug combinations [Study 2]

| PRJNA488236 | ENA

Transcriptomic profiles of tissues from rats treated with drug combinations [Study 1]

Project description:Transcriptomic profiles of tissues from rats treated with drug combinations [Study 1]

| PRJNA488229 | ENA

Transcriptomic analysis of insulin-sensitive tissues from anti-diabetic drug treated ZDF rats, a T2DM animal model.

Project description:Gene expression changes have been associated with type 2 diabetes mellitus (T2DM); however, the alterations are not fully understood. We investigated the effects of anti-diabetic drugs on gene expression in Zucker diabetic fatty (ZDF) rats using oligonucleotide microarray technology to identify gene expression changes occurring in T2DM. Global gene expression in the pancreas, adipose tissue, skeletal muscle, and liver was profiled from Zucker lean control (ZLC) and anti-diabetic drug treated ZDF rats compared with those in ZDF rats. We showed that anti-diabetic drugs regulate the expression of a large number of genes. We provided a more integrated view of the diabetic changes by examining the gene expression networks. The resulting sub-networks allowed us to identify several biological processes that were significantly enriched by the anti-diabetic drug treatment, including oxidative phosphorylation (OXPHOS), systemic lupus erythematous, and the chemokine signaling pathway. Among them, we found that white adipose tissue from ZDF rats showed decreased expression of a set of OXPHOS genes that were normalized by rosiglitazone treatment accompanied by rescued blood glucose levels. In conclusion, we suggest that alterations in OXPHOS gene expression in white adipose tissue may play a role in the pathogenesis and drug mediated recovery of T2DM through a comprehensive gene expression network study after multi-drug treatment of ZDF rats.

| S-EPMC3724940 | biostudies-literature

Transcriptomic profiling of drug-treated human induced pluripotent stem cells (iPSCs)

Project description:This SuperSeries is composed of the SubSeries listed below.

2022-11-14 | GSE217424 | GEO